Peptide Science Mod GRF (1-29) (CJC-1295 no DAC)

Peptide Science Mod GRF (1-29), also known as CJC-1295 without DAC (Drug Affinity Complex), is a synthetic peptide and a variant of growth hormone-releasing hormone (GHRH). It is designed to stimulate the pituitary gland to release more growth hormone (GH) in the body. Here’s a bit more about it:

Key Features:

1. Sequence: Mod GRF (1-29) is a fragment of the naturally occurring growth hormone-releasing hormone (GHRH), specifically the first 29 amino acids.
2. CJC-1295 (without DAC): The term “CJC-1295” refers to a modified version of the GHRH with a longer half-life, but without the addition of the DAC (Drug Affinity Complex). The DAC provides a prolonged release of the peptide, and without it, the peptide has a relatively shorter half-life.
3. Action: It promotes the release of growth hormone from the pituitary gland. The peptide works by binding to the GHRH receptors on the pituitary cells, which stimulates the release of endogenous growth hormone.
4. Benefits: It is commonly used in research and bodybuilding for its potential to increase growth hormone levels, which may support muscle growth, fat loss, improved recovery, and overall well-being.
5. Administration: Typically administered via subcutaneous injection, with effects being noticed over time with regular use.

Comparison to Other GHRH Peptides:

• CJC-1295 with DAC: This form has a much longer duration of action due to the inclusion of DAC, which prolongs its effect on growth hormone secretion. The version you’re referring to (without DAC) will have a much shorter half-life and typically requires more frequent dosing.

Possible Side Effects:

• Injection Site Reactions: Pain, redness, or swelling at the injection site.
• Water Retention: Some users may experience mild water retention due to increased growth hormone levels.
• Potential Pituitary Effects: Long-term use of growth hormone-releasing peptides may lead to alterations in the body’s natural growth hormone regulation.